Article Information
PubMed
Print ISSN
Online ISSN
History
- Received April 2, 2022
- Accepted May 25, 2022
- Published online December 22, 2022.
Article Versions
- Earlier version (June 28, 2022 - 09:29).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Jessica Gambardella1,
- Antonella Fiordelisi1,
- Daniela Sorriento,
- Federica Cerasuolo,
- Antonietta Buonaiuto,
- Roberta Avvisato,
- Antonio Pisani,
- Fahimeh Varzideh,
- Eleonora Riccio,
- Gaetano Santulli2, and
- Guido Iaccarino2
- Department of Advanced Biomedical Sciences (J.G., A.F., D.S., F.C., A.B., R.A., G.I.); Interdepartmental Center of Research on Hypertension and Related Conditions (J.G., G.I.), and Department of Public Health (A.P., E.R.); Federico II University, Naples, Italy; and Departments of Medicine (Cardiology) and Molecular Pharmacology, Wilf Family Cardiovascular Research Institute, Institute for Neuroimmunology and Inflammation, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research, Einstein-Sinai Diabetes Research Center, Albert Einstein College of Medicine, New York City, New York (J.G., F.V., G.S.)
- Address correspondence to:
Prof. Guido Iaccarino, Federico II University, Via Pansini, 5 – 80131, Naples, Italy. E-mail: guiaccar{at}unina.it; or Prof. Gaetano Santulli, Albert Einstein College of Medicine, 1300 Morris Park Avenue, New York City, NY 10461. E-mail: gsantulli001{at}gmail.com